SAN FRANCISCO--(BUSINESS WIRE)--Medivation, Inc. (Nasdaq:MDVN) today issued a reminder that it will host an investor conference call and live audio webcast on Wednesday, July 6, 2016 at 4:30 p.m. Eastern Time to provide a detailed review of its promising and potentially best-in-class PARP inhibitor talazoparib.
